Trials / Terminated
TerminatedNCT00519194
CONcomitant eValuation of Epicor Left atRial Therapy for AF
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the safety and efficacy of the Epicor LP Cardiac Ablation System for treating permanent atrial fibrillation during concomitant open chest and/or open heart surgery for one of more of the following procedures: mitral valve repair or replacement, aortic valve repair or replacement, tricuspid valve repair or replacement, coronary artery bypass surgery or patent foramen ovale (PFO closure).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Epicor LP Cardiac Ablation System | Surgical ablation of permanent AF during concomitant open chest and/or open heart surgery |
| PROCEDURE | Surgical ablation of permanent AF | Concomitant AF ablation during mitral valve surgery |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2007-08-22
- Last updated
- 2019-02-19
- Results posted
- 2014-05-05
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00519194. Inclusion in this directory is not an endorsement.